Local, Quantitative Morphometry of Fibroproliferative Lung Injury using Laminin

Investigations into the mechanisms of injury and repair in pulmonary fibrosis require consideration of the spatial heterogeneity inherent in the disease. Most scoring of fibrotic remodeling in preclinical animal models rely on the modified Ashcroft score, which is a semi-quantitative scoring rubric of macroscopic resolution. The obvious limitations inherent in manual pathohistological grading have generated an unmet need for unbiased, repeatable scoring of fibroproliferative burden in tissue. Using computer vision approaches on immunofluorescent imaging of the extracellular matrix (ECM) component laminin, we generate a robust and repeatable quantitative remodeling scorer (QRS). In the bleomycin lung injury model, QRS shows significant agreement with modified Ashcroft scoring with a significant Spearman coefficient r=0.768. This antibody-based approach is easily integrated into larger multiplex immunofluorescent experiments, which we demonstrate by testing the spatial apposition of tertiary lymphoid structures (TLS) to fibroproliferative tissue. The tool reported in this manuscript is available as a standalone application which is usable without programming knowledge.

[1]  C. E. Perlman,et al.  Update on the Features and Measurements of Experimental Acute Lung Injury in Animals: An Official American Thoracic Society Workshop Report , 2022, American journal of respiratory cell and molecular biology.

[2]  Maxwell L. Smith The histologic diagnosis of usual interstitial pneumonia of idiopathic pulmonary fibrosis. Where we are and where we need to go , 2021, Modern Pathology.

[3]  Kevin J. O'Brien,et al.  Automated Digital Quantification of Pulmonary Fibrosis in Human Histopathology Specimens , 2021, Frontiers in Medicine.

[4]  T. Barker,et al.  Extracellular matrix remodeling associated with bleomycin-induced lung injury supports pericyte-to-myofibroblast transition , 2020, bioRxiv.

[5]  Naftali Kaminski,et al.  Single Cell RNA-seq reveals ectopic and aberrant lung resident cell populations in Idiopathic Pulmonary Fibrosis , 2019, bioRxiv.

[6]  J. Soriano,et al.  Idiopathic Pulmonary Fibrosis: Epidemiology, Natural History, Phenotypes , 2018, Medical sciences.

[7]  M. Glassberg,et al.  Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis , 2018, Front. Med..

[8]  C. Hogaboam,et al.  Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis , 2017, Current Pathobiology Reports.

[9]  R. Chambers,et al.  An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis , 2017, American journal of respiratory cell and molecular biology.

[10]  J. Gilhodes,et al.  Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis , 2017, PloS one.

[11]  Peter Bankhead,et al.  QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.

[12]  R. Strieter What Differentiates Normal Lung Repair and Fibrosis , 2012 .

[13]  W. Rom,et al.  An official American Thoracic Society workshop report: Climate change and human health. , 2012, Proceedings of the American Thoracic Society.

[14]  H. Bolte,et al.  Standardized quantification of pulmonary fibrosis in histological samples. , 2008, BioTechniques.

[15]  J M Simpson,et al.  Simple method of estimating severity of pulmonary fibrosis on a numerical scale. , 1988, Journal of clinical pathology.

[16]  S. Rosselot Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).